OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Systolic Blood Pressure Time in Target Range and Incident Atrial Fibrillation in Patients With Hypertension: Insights From the SPRINT Trial
Jue Wang, Chao Jiang, Sitong Li, et al.
Hypertension (2023) Vol. 80, Iss. 11, pp. 2306-2314
Open Access | Times Cited: 15
Jue Wang, Chao Jiang, Sitong Li, et al.
Hypertension (2023) Vol. 80, Iss. 11, pp. 2306-2314
Open Access | Times Cited: 15
Showing 15 citing articles:
Research Progress on the Mechanism of Action and Efficacy of Sacubitril/Valsartan in the Treatment of Atrial Fibrillation
蕊 刘
Advances in Clinical Medicine (2025) Vol. 15, Iss. 01, pp. 127-131
Open Access
蕊 刘
Advances in Clinical Medicine (2025) Vol. 15, Iss. 01, pp. 127-131
Open Access
Blood Pressure Time in Target Range Within 24 Hours and Cardiovascular Diseases and Mortality: Perspectives From a Real-World Cohort Study
Xue Tian, Xiaoli Zhang, Shuohua Chen, et al.
Mayo Clinic Proceedings (2025)
Closed Access
Xue Tian, Xiaoli Zhang, Shuohua Chen, et al.
Mayo Clinic Proceedings (2025)
Closed Access
Sex-Specific Association between Systolic Blood Pressure Time in Target Range and Cardiovascular Outcomes: A Post-Hoc Analysis of the SPRINT Trial
Yuekun Zhang, Wen Zheng, Chao Jiang, et al.
Reviews in Cardiovascular Medicine (2025) Vol. 26, Iss. 3
Open Access
Yuekun Zhang, Wen Zheng, Chao Jiang, et al.
Reviews in Cardiovascular Medicine (2025) Vol. 26, Iss. 3
Open Access
Systolic blood pressure variability: risk of cardiovascular events, chronic kidney disease, dementia, and death
Xunjie Cheng, Chao Song, Feiyun Ouyang, et al.
European Heart Journal (2025)
Open Access
Xunjie Cheng, Chao Song, Feiyun Ouyang, et al.
European Heart Journal (2025)
Open Access
Ambulatory blood pressure monitoring, European guideline targets, and cardiovascular outcomes: an individual patient data meta-analysis
Dong‐Yan Zhang, De‐Wei An, Yu‐Ling Yu, et al.
European Heart Journal (2025)
Open Access
Dong‐Yan Zhang, De‐Wei An, Yu‐Ling Yu, et al.
European Heart Journal (2025)
Open Access
Development and trends in research on hypertension and atrial fibrillation: A bibliometric analysis from 2003 to 2022
Nan Tang, Qiang Zhou, Shuang Liu, et al.
Medicine (2024) Vol. 103, Iss. 21, pp. e38264-e38264
Open Access | Times Cited: 2
Nan Tang, Qiang Zhou, Shuang Liu, et al.
Medicine (2024) Vol. 103, Iss. 21, pp. e38264-e38264
Open Access | Times Cited: 2
Systolic blood pressure time in target range within 24 hours and incident heart failure: insights from the real-world setting
Xue Tian, Yijun Zhang, Shuohua Chen, et al.
Hypertension Research (2024) Vol. 48, Iss. 1, pp. 223-232
Closed Access | Times Cited: 2
Xue Tian, Yijun Zhang, Shuohua Chen, et al.
Hypertension Research (2024) Vol. 48, Iss. 1, pp. 223-232
Closed Access | Times Cited: 2
Cumulative blood pressure load and hypertensive nephropathy in Han Chinese hypertensive patients
K.-W. Liu, Ming‐Hui Hung, Chin‐Chou Huang, et al.
Journal of Clinical Hypertension (2024) Vol. 26, Iss. 2, pp. 207-216
Open Access | Times Cited: 1
K.-W. Liu, Ming‐Hui Hung, Chin‐Chou Huang, et al.
Journal of Clinical Hypertension (2024) Vol. 26, Iss. 2, pp. 207-216
Open Access | Times Cited: 1
Changing Concepts About Optimal Target Blood Pressure and the Therapeutic Advantages of Azilsartan for Achieving it
S. R. Gilarevsky
Kardiologiia (2024) Vol. 64, Iss. 4, pp. 61-70
Closed Access | Times Cited: 1
S. R. Gilarevsky
Kardiologiia (2024) Vol. 64, Iss. 4, pp. 61-70
Closed Access | Times Cited: 1
Protocol for a randomized controlled trial of intensive blood pressure control on cardiovascular risk reduction in patients with atrial fibrillation: rationale and design of the CRAFT trial
Chao Jiang, Zhiyan Wang, Xin Du, et al.
American Heart Journal (2024) Vol. 278, pp. 33-40
Closed Access | Times Cited: 1
Chao Jiang, Zhiyan Wang, Xin Du, et al.
American Heart Journal (2024) Vol. 278, pp. 33-40
Closed Access | Times Cited: 1
Systolic Blood Pressure Time in Target Range and Cardiovascular Disease and Premature Death
Xu Han, Shuting Liu, Xin Zhou, et al.
JACC Asia (2024) Vol. 4, Iss. 12, pp. 987-996
Open Access | Times Cited: 1
Xu Han, Shuting Liu, Xin Zhou, et al.
JACC Asia (2024) Vol. 4, Iss. 12, pp. 987-996
Open Access | Times Cited: 1
Time in Target Blood Pressure Range for the Prediction of Atrial Fibrillation in Treated Hypertension
J. Xia, Ying Zhang, Ji‐Guang Wang
Hypertension (2023) Vol. 80, Iss. 11, pp. 2315-2317
Closed Access | Times Cited: 1
J. Xia, Ying Zhang, Ji‐Guang Wang
Hypertension (2023) Vol. 80, Iss. 11, pp. 2315-2317
Closed Access | Times Cited: 1
Blood Pressure Time in Target Range and its Impact on Clinical Outcomes
Astefanos Al-Dalakta, Chadi Tabaja, Issam Motairek, et al.
Current Cardiology Reports (2024) Vol. 26, Iss. 10, pp. 1145-1151
Open Access
Astefanos Al-Dalakta, Chadi Tabaja, Issam Motairek, et al.
Current Cardiology Reports (2024) Vol. 26, Iss. 10, pp. 1145-1151
Open Access
The association of out-of-office blood pressure time in target range with clinical outcomes
Chang Chen, Chen Liu, Jan A. Staessen, et al.
Hypertension Research (2024) Vol. 48, Iss. 1, pp. 420-422
Closed Access
Chang Chen, Chen Liu, Jan A. Staessen, et al.
Hypertension Research (2024) Vol. 48, Iss. 1, pp. 420-422
Closed Access
Association Between Systolic Blood Pressure Time in Target Range Indices and Adverse Cardiovascular Outcomes
Moran Li, Song Zhao, Shikai Yu, et al.
JACC Advances (2024) Vol. 3, Iss. 11, pp. 101350-101350
Open Access
Moran Li, Song Zhao, Shikai Yu, et al.
JACC Advances (2024) Vol. 3, Iss. 11, pp. 101350-101350
Open Access
